The role of
IL-10, a primarily anti-inflammatory
cytokine, in the regulation of inflammatory lymphangiogenesis is undetermined. Herein, we show that
IL-10 modulates corneal lymphangiogenesis and resolution of
inflammation.
IL-10 was not expressed in healthy corneas but was up-regulated in inflamed corneas by infiltrating macrophages. Macrophages up-regulated the expression of prolymphangiogenic
vascular endothelial growth factor-C upon stimulation with
IL-10. Consistently, corneal
inflammation resulted in reduced expression of
vascular endothelial growth factor-C and decreased corneal lymphangiogenesis in IL-10-deficient mice (IL-10(-/-)). The effect of
IL-10 on lymphangiogenesis was indirect via macrophages, because
IL-10 did not directly affect lymphatic endothelial cells. The expression of proinflammatory
cytokines and the numbers of infiltrating macrophages increased and remained elevated in inflamed corneas of IL-10(-/-) mice, indicating that
IL-10 deficiency led to more severe and prolonged
inflammation. The corneal phenotype of
IL-10 deficient mice was mimicked in mice with conditional deletion of Stat3 in myeloid cells (
lysozyme M Cre mice Stat3(fl/fl) mice), corroborating the critical role of macrophages in the regulation of lymphangiogenesis. Furthermore, local treatment with
IL-10 promoted lymphangiogenesis and faster egress of macrophages from inflamed corneas. Taken together, we demonstrate that
IL-10 indirectly regulates inflammatory corneal lymphangiogenesis via macrophages. Reduced lymphangiogenesis in IL-10(-/-) and
lysozyme M Cre Stat3(fl/fl) mice is associated with more severe inflammatory responses, whereas
IL-10 treatment results in faster resolution of
inflammation.
IL-10 might be used therapeutically to terminate pathological
inflammation.